Inactivation of NF-κB2 (p52) restrains hepatic glucagon response via preserving PDE4B induction
Elevated glucagon level in obesity and diabetes promotes hepatic glucose production and hyperglycemia. Here the authors report that NF-κB2 augments the hepatic glucagon responses by inhibiting PDE4B induction, and that metformin lowers blood glucose in part by inhibiting NF-κB2.
Main Authors: | Wen-Song Zhang, An Pan, Xu Zhang, Ang Ying, Gaoxiang Ma, Bao-Lin Liu, Lian-Wen Qi, Qun Liu, Ping Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2019-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-12351-x |
Similar Items
-
Origin of the Functional Distinctiveness of NF-κB/p52
by: Gourisankar Ghosh, et al.
Published: (2021-11-01) -
Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma
by: Xiangjun Yang, et al.
Published: (2020-08-01) -
Atypical IκB Bcl3 enhances the generation of the NF-κB p52 homodimer
by: Wenfei Pan, et al.
Published: (2022-08-01) -
FOXC1 restrains NF‐κB‐mediated interleukin‐1β transcription in breast cancer
by: Yan Liu, et al.
Published: (2023-12-01) -
Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation
by: Wen Guo, et al.
Published: (2021-05-01)